Lineage Cell Therapeutics Inc - ESG Rating & Company Profile powered by AI
The report of Lineage Cell Therapeutics Inc uses data from across the internet as well as from available filings by Lineage Cell Therapeutics Inc. The webpage is a free Sustainability analysis covering Lineage Cell Therapeutics Inc. This webpage contains a Q&A table about Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 0.0, social score of 0.0 and governance score of 4.8.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | Lineage Cell Therapeutics Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Lineage Cell Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Lineage Cell Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Lineage Cell Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Lineage Cell Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Lineage Cell Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Lineage Cell Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Lineage Cell Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also develops Renevia, a facial aesthetics product that is in pivotal clinical trial for the treatment of HIV-associated facial lipoatrophy; ReGlyde, a HyStem product in preclinical development as a device for viscosupplementation, and as a platform for intraarticular drug delivery in osteoarthritis; and Premvia, a Hystem Hydrogel product, as well as develop bone grafting products for the orthopedic diseases and injuries. In addition, it markets GeneCards, a human gene database; MalaCards, a human disease database; and Hextend, a plasma volume expander used to treat or prevent hypovolemia, including albumin, generic 6% hetastarch solutions, and crystalloid solutions, as well as undertakes various research programs for vision restoration and Demyelination. The company has collaboration with Orbit Biomedical, Ltd. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California.